Mazdutide (IBI362, OXM3) is a long-acting acylated peptide with balanced agonist activity at both the GLP-1 receptor and the glucagon receptor. Structurally derived from oxyntomodulin, it provides synergistic effects on appetite suppression and energy expenditure.
Research Applications:
- Metabolic syndrome and obesity research models
- Hepatic steatosis and NAFLD/NASH studies
- Comparative dual vs. single agonist receptor pharmacology
- Insulin secretion and beta-cell function research
Key Properties:
Receptor Targets: GLP-1R, GCGR
Structural Basis: Oxyntomodulin-derived, fatty acid acylated
CAS: 2413389-79-2
Product Specifications:
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: −20 °C, protected from light
For research use only. Not for human consumption. Not for veterinary use. No medical or therapeutic claims are made. These statements have not been evaluated by the FDA.

Reviews
There are no reviews yet.